Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 2—February 2015
Research

Simulation Study of the Effect of Influenza and Influenza Vaccination on Risk of Acquiring Guillain-Barré Syndrome

Steven Hawken, Jeffrey C. Kwong, Shelley L. Deeks, Natasha S. Crowcroft, Allison McGeer, Robin Ducharme, Michael A. Campitelli, Doug Coyle, and Kumanan WilsonComments to Author 
Author affiliations: Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada (S. Hawken, J.C. Kwong, R. Ducharme, M.A. Campitelli, K. Wilson); Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (S. Hawken, R. Ducharme, K. Wilson); University of Ottawa, Ottawa (S. Hawken, D. Coyle, K. Wilson); Public Health Ontario, Toronto (J.C. Kwong, S.L. Deeks, N.S. Crowcroft); Dalla Lana School of Public Health, University of Toronto, Toronto (J.C. Kwong, S.L. Deeks, N.S. Crowcroft, A.J. McGeer); University of Toronto, Toronto (J.C. Kwong, N.S. Crowcroft, A.J. McGeer)

Main Article

Figure 3

Excess risk of Guillain-Barré syndrome (GBS) per 1,000,000 influenza vaccinations by influenza incidence rate, age, and vaccine effectiveness for both sexes combined. A) Risk for persons <18 years of age; vaccine effectiveness of 40%–80%. B) Risk for persons 45 years of age; vaccine effectiveness of 40%–80%. C) Risk for persons 60 years of age; vaccine effectiveness of 20%–80%. D) Risk for persons 75 years of age; vaccine effectiveness of 20%–80%. Depending on the joint distribution of the pr

Figure 3. Excess risk of Guillain-Barré syndrome (GBS) per 1,000,000 influenza vaccinations by influenza incidence rate, age, and vaccine effectiveness for both sexes combined. A) Risk for persons <18 years of age; vaccine effectiveness of 40%–80%. B) Risk for persons 45 years of age; vaccine effectiveness of 40%–80%. C) Risk for persons 60 years of age; vaccine effectiveness of 20%–80%. D) Risk for persons 75 years of age; vaccine effectiveness of 20%–80%. Depending on the joint distribution of the probabilistic inputs to the simulation model, these deterministic sensitivity analyses will not necessarily yield identical mean/median estimates to those from the probabilistic simulation for the same age, sex, and influenza incidence rate.

Main Article

Page created: January 20, 2015
Page updated: January 20, 2015
Page reviewed: January 20, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external